2 active not recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
Follow ATM Gene Mutation: new trials by email Literature Review of ATM Gene Mutation trials Research Report on ATM Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors Olaparib, ASTX727 - BRCA1 Mutation, BRCA2 Mutation | Phase 1 | Active not recruiting | Varun Monga, MBBS | 13 | 2024-02-07 | 2026-10-20 |
| Combination Therapy in Cancers With Mutations in DNA Repair Genes Niraparib, Irinotecan - Metastatic Solid Tumor, BRCA1 Mutation | Phase 1 | Active not recruiting | University of California, San Francisco | 24 | 2023-05-23 | 2026-11-12 |
Neoplasms (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Irinotecan (1) · decitabine and cedazuridine drug combination (1) · niraparib (1) · olaparib (1) · small molecule inhibitor THX-B (1)
University of California, San Francisco (1) · Varun Monga, MBBS (1)
United States (2)
R01CA255613 (1)